Clinical Trial Update: Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) [Phase 2]

View source ↗

Summary

The Phase 2b ALPINE 2/3 trial evaluating aldafermin in adults with nonalcoholic steatohepatitis and stage 2/3 fibrosis has completed, and results including safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Aldafermin (aldafermin)

Snippet

Sponsor: NGM Biopharmaceuticals, Inc | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-07-03